|Articles|December 6, 2021
Tailored, Dedicated Support Expedites COVID-19 Vaccine Trial
Author(s)WCG
Site augmentation helps expedite COVID-19 vaccine trial by enrolling over 30,000 study participants in just over three months.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
FDA Approves Subcutaneous Lunsumio VELO Based on GO29781 Trial Results in Relapsed or Refractory Follicular Lymphoma
2
Applying AI to Automate Workflows Without Disrupting Sites
3
ACT Brief: Building a Digital Thread in Life Sciences, CRO Sourcing Decisions and Site Burden, and Lilly’s Oral GLP-1 Phase III Results
4
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results
5